Immune-Therapy-Related Toxicity Events and Dramatic Remission After a Single Dose of Pembrolizumab Treatment in Metastatic Thymoma: A Case Report

Immune checkpoint inhibitor therapy has become a promising option for the treatment of late-stage thymic epithelial tumors. In this manuscript, we presented a patient with metastatic thymoma administrated of anti-programmed cell death protein 1 (PD-1) antibody pembrolizumab. Although the patient und...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Li, Chen, Haiyan, Wei, Qichun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8082155/
https://www.ncbi.nlm.nih.gov/pubmed/33936037
http://dx.doi.org/10.3389/fimmu.2021.621858

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8082155/
https://www.ncbi.nlm.nih.gov/pubmed/33936037
http://dx.doi.org/10.3389/fimmu.2021.621858

Ejemplares similares